Retaglutide is a novel GLP-1 receptor agonist currently under study for the control of type 2 diabetes. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://declanrerv389476.blogsvirals.com/37831323/trelaglutide-exploring-a-new-treatment-for-chronic-diseases